Literature DB >> 26122590

Whipple's pancreaticoduodenectomy: Surgical technique and perioperative clinical outcomes in a single center.

Giorgio Romano1, Antonino Agrusa2, Massimo Galia3, Giuseppe Di Buono4, Daniela Chianetta5, Vincenzo Sorce6, Leonardo Gulotta7, Giuseppe Brancatelli8, Gaspare Gulotta9.   

Abstract

INTRODUCTION: Pancreatic cancer is the fourth cause of death from cancer in Western countries. The radical surgical resection is the only curative option for this pathology. The prevalence of this disease increases with age in population. The causes of pancreatic cancer are unknown, but we consider risk factors like smoke and tobacco usage, alcohol consumption coffee, history of diabetes or chronic pancreatitis. In this study we report our experience in the treatment of resectable pancreatic cancer and periampullary neoplasms with particular attention to evaluate the evolution of surgical technique and the clinical postoperative outcomes.
METHODS: In our Department between January 2010 and December 2014 we performed a total of 97 pancreaticoduodenectomy. We considered only resectable pancreatic cancer and periampullary neoplasms defined by absence of distant metastases, absence of local tumor extension to the celiac axis and hepatic artery as the lack of involvement of the superior mesenteric vasculature. None of these patients received neoadjuvant chemotherapy.
RESULTS: The mean age of these patients was 64.5 years. Jaundice was the commonest presenting symptom associated to anorexia and weight loss. The mean operative time was 295 min (± 55 min). The mean blood loss was 450 ml and median blood transfusion was 1 units. 12.1% of patients had an intra-abdominal complication. The commonest complication was Delayed Gastric Emptying responsable of increased length of hospital stay and readmission rate. Postoperative pancreatic fistula of grade C occurred in 4 patients. 2 patients developed a postpancreatectomy hemorrhage. Perioperative mortality was 4.1%.
CONCLUSION: Pancreaticoduodenectomy is a complex surgical technique and the associated high morbidity and mortality resulted in initial reluctance to adopt this surgery for the management of pancreatic and periampullary tumors. Surgical outcomes of pancreatic surgery are better at high-volume experienced center reporting mortality rates below 5%. We perform an end-to-side duct-to-mucosa pancreaticojejunostomy with routinely use of internal pancreatic stent. However no one technique has been shown to definitely be the solution to the problem of postoperative pancreatic fistula. At our center we have a reasonable volume and our data are comparable to literature data.
Copyright © 2015 IJS Publishing Group Limited. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Clinical outcomes; Pancreatic cancer; Pancreaticoduodenectomy; Postoperative pancreatic fistula; Whipple procedure

Mesh:

Year:  2015        PMID: 26122590     DOI: 10.1016/j.ijsu.2015.06.062

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  14 in total

1.  Editorial: Management of the Small Asymptomatic Pancreatic Cyst: Somehow Along the Way We Forgot About the Patient.

Authors:  C Mel Wilcox
Journal:  Am J Gastroenterol       Date:  2017-08       Impact factor: 10.864

2.  Perioperative Management of Pancreaticoduodenectomy: Avoiding Admission to the Intensive Care Unit.

Authors:  Walid Faraj; Deborah Mukherji; Ahmad M Zaghal; Hussein Nassar; Farah H Mokadem; Samar Jabbour; Chakib Ayoub; Marwan S Rizk; Mariam Kanso; Rola F Jaafar; Nigel Heaton; Mohamad Khalife
Journal:  Gastrointest Tumors       Date:  2019-09-17

3.  Impact Factors for Perioperative Morbidity and Mortality and Repercussion of Perioperative Morbidity and Long-term Survival in Pancreatic Head Resection.

Authors:  Stojan Potrc; Arpad Ivanecz; Vid Pivec; Urska Marolt; Sasa Rudolf; Bojan Iljevec; Tomaz Jagric
Journal:  Radiol Oncol       Date:  2017-09-14       Impact factor: 2.991

4.  A modified single jejunal loop reconstruction by performing proximal gastrojejunostomy after Whipple's pancreticoduodenectomy in a low-volume hospital.

Authors:  Ali Naki Yücesoy
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2019-02-28

5.  Dedifferentiated retroperitoneal large liposarcoma and laparoscopic treatment: Is it possible and safe? The first literature case report.

Authors:  Antonino Agrusa; Giuseppe Di Buono; Salvatore Buscemi; Brenda Randisi; Leonardo Gulotta; Vincenzo Sorce; Giuseppe Badalamenti; Domenico Albano; Massimo Galia; Giorgio Romano; Gaspare Gulotta
Journal:  Int J Surg Case Rep       Date:  2019-03-26

6.  Perioperative factors impacting intensive care outcomes following Whipple procedure: A retrospective study.

Authors:  R Udhayachandhar; J Otokwala; Pritish J Korula; Manbha Rymbai; Tony T Chandy; Philip Joseph
Journal:  Indian J Anaesth       Date:  2020-03-11

7.  The effect of atrial fibrillation on perioperative outcomes in patients with pancreatic cancer undergoing open pancreaticoduodenectomy: analysis of the National Inpatient Sample.

Authors:  Pu Han; Yifeng Yang; Yanjie He; Hongwei Wu; Dong Wang; Kun Liu; Chengjian Guan; Xiaodong Zhang; Wei Guo; Zhongtao Zhang
Journal:  Gland Surg       Date:  2021-06

Review 8.  Postoperative Complications, In-Hospital Mortality and 5-Year Survival After Surgical Resection for Patients with a Pancreatic Neuroendocrine Tumor: A Systematic Review.

Authors:  Anneke P J Jilesen; Casper H J van Eijck; K H in't Hof; S van Dieren; Dirk J Gouma; Els J M Nieveen van Dijkum
Journal:  World J Surg       Date:  2016-03       Impact factor: 3.352

9.  Laparoscopic management of cholecystocolonic fistula: A case report and a brief literature review.

Authors:  G Bonventre; G Di Buono; S Buscemi; G Romano; A Agrusa
Journal:  Int J Surg Case Rep       Date:  2020-02-28

10.  A rare case of idiopathic cholestasis: Clinical conundrums complicating enzalutamide therapy in metastatic prostate cancer.

Authors:  Jun Liu; George Agyapong; Debashish Misra; C Douglas Taylor; David A Hirsh
Journal:  Clin Case Rep       Date:  2019-09-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.